Coryandar Glivary (PhD)


Coryandar (Cory) Gilvary obtained her PhD from Weill Cornell under the direction of Olivier Elemento, where she completed her PhD in record time (~ 3 years). At Weill Cornell her research focused on developing new machine learning techniques for drug development spanning different disease areas like cancer, diabetes and Parksinson’s disease.

Outside of her computational biology research, she spent time developing cutting edge machine learning models at one of the world’s leading quantitative hedge funds.

Currently, Cory leads OneThree’s data science and computational biology efforts and many of her early research projects helped form the core OneThree platform. Most recently she spearheaded OneThree’s internal efforts to provide free toxicity screening to any researchers working on treatment for COVID-19. 

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound